Amit Jogi leads the CDMO Biologics business at Aurigene Pharmaceutical Services Ltd., with over two and a half decades of experience in biologics development and manufacturing. His expertise spans process development, manufacturing science and technology, scale-up, and clinical and commercial manufacturing, with a strong focus on monoclonal antibodies and bispecific antibodies. Throughout his career, Amit has led more than 30+ process development programs and contributed to over 25+ biologic products (Novel Biologics and Biosimilars) for clinical and commercial manufacturing. A bioprocess technologist with a Ph.D. in Microbiology, he combines scientific expertise with extensive leadership experience in the CDMO and CMO industry. Amit is also an author, researcher, and international speaker, with a co-authored book and multiple scientific publications